Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Akoya Biosciences, Inc. (AKYA)

Compare
1.3700
-0.0600
(-4.20%)
As of 11:49:00 AM EDT. Market Open.
Loading Chart for AKYA
  • Previous Close 1.4300
  • Open 1.3800
  • Bid 0.9792 x 200
  • Ask 1.7200 x 200
  • Day's Range 1.3300 - 1.3900
  • 52 Week Range 1.3300 - 4.6900
  • Volume 85,692
  • Avg. Volume 686,225
  • Market Cap (intraday) 68.248M
  • Beta (5Y Monthly) 1.32
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1200
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.14

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

www.akoyabio.com

205

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AKYA

View More

Performance Overview: AKYA

Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AKYA
40.17%
S&P 500 (^GSPC)
5.53%

1-Year Return

AKYA
70.79%
S&P 500 (^GSPC)
5.75%

3-Year Return

AKYA
87.53%
S&P 500 (^GSPC)
22.65%

5-Year Return

AKYA
94.73%
S&P 500 (^GSPC)
114.98%

Compare To: AKYA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AKYA

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    71.24M

  • Enterprise Value

    120.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.87

  • Price/Book (mrq)

    9.38

  • Enterprise Value/Revenue

    1.47

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -67.79%

  • Return on Assets (ttm)

    -16.86%

  • Return on Equity (ttm)

    -180.45%

  • Revenue (ttm)

    81.67M

  • Net Income Avi to Common (ttm)

    -55.37M

  • Diluted EPS (ttm)

    -1.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35.04M

  • Total Debt/Equity (mrq)

    1,107.91%

  • Levered Free Cash Flow (ttm)

    -26.52M

Research Analysis: AKYA

View More

Company Insights: AKYA

Research Reports: AKYA

View More

People Also Watch